We're aware of a cyber security incident affecting the electronic prescriptions provider MediSecure. The eRX Script Exchange (eRX) and the National Prescription Delivery Service (NPDS) continue to operate as usual and have not been impacted. Find out more and read our statement here.

Submission to the MBS Review – Consumer Panel Report

Last updated 7 January 2020


Date: 20 December 2019

The RACGP has provided a submission to the MBS Review Taskforce regarding the report from the Consumer Panel.

The Consumer Panel has recommended that the MBS review be underscored by a number of principles, including that the MBS review supports the development of an Australian healthcare system that is safe and high quality; provides equity of access and outcome for patients; delivers improvements in patient outcomes; supports the efficient and effective use of resources; and is sustainable. The RACGP submission expresses support for this recommendation.

The RACGP submission also requests further information on the Consumer Panel’s recommendations to look at the scope of practice of more than one clinical group, and to inhibit the listing of multiple MBS items for single consultations or treatments.

Read the submission

RACGP submission to the Consumer Panel (PDF 193 KB)